
AMH Or Follicle Count Which Matters More For Endometriomas
How AMH and antral follicle count behave with unilateral or bilateral endometriomas, the impact of cyst size, and practical guidance for your next appointment.
Your options, your surgeon, and how to begin, on one page.
See the overview
Explore all our service offerings from one place.
Browse services
Search expert-written answers, browse by topic, or find information based on where you are in your journey.
Explore All KnowledgeExplore genetic, proteomic, hormonal, and microbiome markers that aim to enable earlier, less invasive diagnosis, stratify risk, guide therapy, and monitor response.
Biomarkers are measurable signals in blood, urine, saliva, menstrual effluent, or tissue that may reflect the presence or activity of endometriosis. Researchers are studying proteins (such as CA-125 and cytokines), small RNAs, cell-free DNA, and microbiome patterns to enable earlier, less invasive detection, classify subtypes, and track treatment response. These tools are designed to complement clinical assessment and imaging, not replace them.
Right now, no single biomarker is accurate enough for routine diagnosis. Combination panels may perform better, and promising work includes menstrual effluent testing and multi-omics paired with machine learning. Learn what common labs can and cannot tell you today, how signals may vary across deep disease and endometriomas, and how results could integrate with Ultrasound and MRI. Because microbes and immune pathways are part of this story, the microbiome’s role connects with Gut Health, while inherited risk relates to Genetics. Stay informed as investigational tests move toward clinical use within New Treatments.
CA-125 is not a reliable tool for fertility planning in endometriosis. It is a nonspecific inflammation marker. For many patients, a normal result doesn't rule out meaningful endometriosis, and a high value doesn't tell us what the next fertility step should be.
CA-125 is not a reliable way to diagnose endometriosis. It can be normal when endometriosis is present or high for other reasons, including other pelvic conditions and benign inflammation, so results usually don’t clarify whether endometriosis is causing your symptoms.
Yes, adenomyosis can be associated with a raised CA-125, a marker that can rise with inflammation and irritation in the pelvis. An elevated result does not diagnose adenomyosis on its own or show how severe it is, and it can have other causes.
Non-invasive tests for endometriosis are getting closer, but none have consistently met the accuracy needed to diagnose it reliably on their own. In the near term, biomarkers are expected to support decisions rather than replace expert imaging or laparoscopy.

How AMH and antral follicle count behave with unilateral or bilateral endometriomas, the impact of cyst size, and practical guidance for your next appointment.

Learn how genetics shapes endometriosis (familial clustering, gene mapping, GWAS, and genomics) and what this means for diagnosis, treatment, and monitoring.

Explore how the microbiome may shape inflammation and estrogen metabolism in endometriosis, and what emerging research means for diagnosis and new therapies.
Lotus Endometriosis Institute provides California-based surgical evaluation and advanced excision care for patients with suspected endometriosis, adenomyosis, complex pelvic pain, and related conditions.
Many patients contact us from outside California to learn whether traveling for in-person evaluation and possible surgery may be appropriate.
2121 Santa Monica Blvd, Santa Monica, CA 90404
8am - 5pm
Monday - Friday
154 Traffic Way, Arroyo Grande, CA 93420